These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19071179)

  • 1. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.
    Tondella ML; Carlone GM; Messonnier N; Quinn CP; Meade BD; Burns DL; Cherry JD; Guiso N; Hewlett EL; Edwards KM; Xing D; Giammanco A; Wirsing von König CH; Han L; Hueston L; Robbins JB; Powell M; Mink CM; Poolman JT; Hildreth SW; Lynn F; Morris A
    Vaccine; 2009 Feb; 27(6):803-14. PubMed ID: 19071179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in serological diagnosis of pertussis by external quality assessment.
    Markey K; Douglas-Bardsley A; Asokanathan C; Fry NK; Barkoff AM; Bacci S; Ködmön C; He Q
    J Med Microbiol; 2019 May; 68(5):741-747. PubMed ID: 30990403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization of Bordetella pertussis real-time PCR diagnostics in the United States in 2012.
    Williams MM; Taylor TH; Warshauer DM; Martin MD; Valley AM; Tondella ML
    J Clin Microbiol; 2015 Jan; 53(1):118-23. PubMed ID: 25355770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative assessment of pertussis diagnostics in United States laboratories.
    Tatti KM; Martin SW; Boney KO; Brown K; Clark TA; Tondella ML
    Pediatr Infect Dis J; 2013 Sep; 32(9):942-5. PubMed ID: 23587980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.
    Xing D; Wirsing von König CH; Newland P; Riffelmann M; Meade BD; Corbel M; Gaines-Das R
    Clin Vaccine Immunol; 2009 Mar; 16(3):303-11. PubMed ID: 19109448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.
    Xing DK; Corbel MJ; Dobbelaer R; Knezevic I
    Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PERISCOPE: road towards effective control of pertussis.
    PERISCOPE Consortium
    Lancet Infect Dis; 2019 May; 19(5):e179-e186. PubMed ID: 30503084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance.
    He Q; Barkoff AM; Mertsola J; Glismann S; Bacci S; ;
    Euro Surveill; 2012 Aug; 17(32):. PubMed ID: 22913939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health. The pertussis paradox.
    Allen A
    Science; 2013 Aug; 341(6145):454-5. PubMed ID: 23908204
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanding Pertussis Epidemiology in 6 Latin America Countries through the Latin American Pertussis Project.
    Pinell-McNamara VA; Acosta AM; Pedreira MC; Carvalho AF; Pawloski L; Tondella ML; Briere E
    Emerg Infect Dis; 2017 Dec; 23(13):S94-S100. PubMed ID: 29155677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB
    Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development.
    Carbonetti NH; Wirsing von König CH; Lan R; Jacob-Dubuisson F; Cotter PA; Deora R; Merkel TJ; van Els CA; Locht C; Hozbor D; Rodriguez ME
    Clin Vaccine Immunol; 2016 Nov; 23(11):842-850. PubMed ID: 27655886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Expert Group on Pertussis Vaccination].
    ; Beltrán Silva S; Cervantes Apolinar Y; Cherry JD; Conde González C; Gentile A; Gómez Altamirano CM; Hernández Porras M; Huerta García G; Macías Parra M; Martínez Aguilar G; Mascareñas de los Santos A; Moreno Espinosa S; Pacheco Ríos A; Prado Cohrs D; Rodriguez Weber MA; Romano Mazzotti L; Rosales Uribe E; Sifuentes Osornio J; Ulloa-Gutiérrez R; Villaseñor Sierra A
    Salud Publica Mex; 2011; 53(1):57-65. PubMed ID: 21340141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The control of pertussis--2007 and beyond.
    Halperin SA
    N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528
    [No Abstract]   [Full Text] [Related]  

  • 19. International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.
    Gaines Das R; Xing D; Rigsby P; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):137-48. PubMed ID: 11580218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
    Bolotin S; Harvill ET; Crowcroft NS
    Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.